ZURICH/BENGALURU, Sept 6 (Reuters) – New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India’s Aurobindo Pharma Ltd for up to $1 billion. The deal, which comes after price pressure hurt the U.S. pills business, includes some 300 products. …read more
Source:: Yahoo Finance